iA Global Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

iA Global Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.9M	Sell	30,054 -861	-3%	-$382K	0.18%	110
2026 Q1	$13.8M	Sell	30,915 -6,770	-18%	-$3.16M	0.2%	105
2025 Q4	$17.1M	Buy	37,685 +1,843	+5%	+$794K	0.22%	98
2025 Q3	$14M	Buy	35,842 +685	+2%	+$286K	0.19%	97
2025 Q2	$15.7M	Sell	35,157 -167	-0.5%	-$77K	0.24%	83
2025 Q1	$17.1M	Sell	35,324 -5,538	-14%	-$2.58M	0.29%	68
2024 Q4	$16.5M	Sell	40,862 -404	-1%	-$187K	0.29%	67
2024 Q3	$19.2M	Sell	41,266 -844	-2%	-$405K	0.34%	61
2024 Q2	$19.7M	Sell	42,110 -696	-2%	-$302K	0.38%	56
2024 Q1	$17.9M	Sell	42,806 -12,142	-22%	-$5.13M	0.37%	55
2023 Q4	$22.4M	Buy	54,948 +5,403	+11%	+$2M	0.52%	45
2023 Q3	$17.2M	Buy	49,545 +10,146	+26%	+$3.55M	0.46%	53
2023 Q2	$13.9M	Buy	+39,399	New	+$13.3M	0.37%	59

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

iA Global Asset Management's VRTX Position: Q2 2026 in Review

iA Global Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 2.8% in Q2 2026, selling an estimated $382K and leaving 30,054 shares worth $14.9M. The position accounts for 0.18% of the portfolio, ranked #110.

iA Global Asset Management first reported a position in VRTX in Q2 2023 and has held it in 13 quarters since. The position peaked at $22.4M in Q4 2023. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

iA Global Asset Management held 30,054 shares of Vertex Pharmaceuticals worth $14.9M as of Q2 2026.
iA Global Asset Management sold 861 Vertex Pharmaceuticals shares in Q2 2026, an estimated $382K.
Vertex Pharmaceuticals made up 0.18% of iA Global Asset Management's portfolio in Q2 2026, its #110 holding.
iA Global Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
iA Global Asset Management's Vertex Pharmaceuticals position peaked at $22.4M in Q4 2023.
1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.